Disease-associated regulation of gene expression by resveratrol: Special focus on the PI3K/AKT signaling pathway
S Ghafouri-Fard, Z Bahroudi, H Shoorei… - Cancer Cell …, 2022 - Springer
Abstract Resveratrol (3, 5, 4′-trihydroxy-trans-stilbene) is a natural phenol that is present in
the skin of the grape, blueberry, raspberry, mulberry, and peanut. This substance is …
the skin of the grape, blueberry, raspberry, mulberry, and peanut. This substance is …
Molecular targeting of the BRAF proto-oncogene/mitogen-activated protein kinase (MAPK) pathway across cancers
KS Shan, TU Rehman, S Ivanov, G Domingo… - International Journal of …, 2024 - mdpi.com
The mitogen-activated protein kinase (MAPK) pathway is essential for cellular proliferation,
growth, and survival. Constitutive activation of this pathway by BRAF mutations can cause …
growth, and survival. Constitutive activation of this pathway by BRAF mutations can cause …
Molecular basis of resveratrol-induced resensitization of acquired drug-resistant cancer cells
CY Choi, SC Lim, TB Lee, SI Han - Nutrients, 2022 - mdpi.com
Multidrug resistance (MDR) to anticancer drugs remains a serious obstacle to the success of
cancer chemotherapy. Resveratrol, a polyphenol, present in natural products exerts …
cancer chemotherapy. Resveratrol, a polyphenol, present in natural products exerts …
Resensitization of Akt Induced Docetaxel Resistance in Breast Cancer by 'Iturin A' a Lipopeptide Molecule from Marine Bacteria Bacillus megaterium
Abstract Development of the resistance is the major problem in cancer therapy. Docetaxel is
a taxol alkaloid that is frequently used in metastatic breast cancer. However, resistance often …
a taxol alkaloid that is frequently used in metastatic breast cancer. However, resistance often …
Current report of natural product development against breast cancer stem cells
A Hermawan, H Putri - The international journal of biochemistry & cell …, 2018 - Elsevier
Chemotherapeutic agents are commonly used as neoadjuvant for breast cancer therapy.
However, there is evidence of treatment failure for most of patients due to acquired …
However, there is evidence of treatment failure for most of patients due to acquired …
The mechanism and consequences of BRAF inhibitor resistance in melanoma
K Golub, W Bai, Z Zhang, H Xiao, R Sun, J Shen… - Genome Instability & …, 2023 - Springer
Abstract BRAF V600E is a constitutive BRAF (B-raf proto-oncogene, serine/threonine
kinase) mutation that accounts for more than 90% of BRAF mutations in melanoma …
kinase) mutation that accounts for more than 90% of BRAF mutations in melanoma …
Melanoma chemoprevention: Current status and future prospects
The incidence of skin cancers, both nonmelanoma and melanoma, is increasing in the
United States. The ultraviolet radiation, mainly from sun, is considered the major cause for …
United States. The ultraviolet radiation, mainly from sun, is considered the major cause for …
[HTML][HTML] T-type calcium channels as potential therapeutic targets in vemurafenib-resistant BRAFV600E melanoma
C Barceló, P Sisó, O Maiques, S Garcia-Mulero… - Journal of Investigative …, 2020 - Elsevier
Melanoma is a malignant neoplasia that is highly resistant to chemotherapy and
radiotherapy and is associated with poor prognosis in advanced stage. Targeting melanoma …
radiotherapy and is associated with poor prognosis in advanced stage. Targeting melanoma …
Unraveling the molecular mechanisms and the potential chemopreventive/therapeutic properties of natural compounds in melanoma
F Fontana, M Raimondi, A Di Domizio… - Seminars in Cancer …, 2019 - Elsevier
Melanoma is the most fatal form of skin cancer. Current therapeutic approaches include
surgical resection, chemotherapy, targeted therapy and immunotherapy. However, these …
surgical resection, chemotherapy, targeted therapy and immunotherapy. However, these …
The dual PI3K/mToR inhibitor omipalisib/GSK2126458 inhibits clonogenic growth in oncogenically-transformed cells from neurocutaneous melanocytosis
D Basu, CM Salgado, B Bauer, Y Khakoo… - Cancer Genomics & …, 2018 - cgp.iiarjournals.org
Background: Omipalisib has been found to affect the viability of cancer cells. However, its
effect on clonogenicity–a feature of cancer stem cells, is not clear. Cells isolated from …
effect on clonogenicity–a feature of cancer stem cells, is not clear. Cells isolated from …